| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Business Officer
1 company
Davis Andrew is a SVP, Chief Business Officer at IRONWOOD PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $1.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | IRWD Ironwood Pharmaceuticals Inc | SVP, Chief Business Officer | Sell | 5,360 | $4.08 | $21,868.80 | -1.8% | -50.2% | -22.6% | |
| May 20, 2024 | IRWD Ironwood Pharmaceuticals Inc | SVP, Chief Business Officer | Sell | 22,725 | $6.45 | $146,576.25 | -7.3% | -25.9% | -89.8% | |
| Feb 12, 2024 | IRWD Ironwood Pharmaceuticals Inc | SVP, Chief Business Officer | Sell | 9,846 | $15.24 | $150,053.04 | -4.5% | -56.5% | -87.8% | |
| Nov 20, 2023 | IRWD Ironwood Pharmaceuticals Inc | SVP, Chief Business Officer | Sell | 3,287 | $9.69 | $31,851.03 | -1.5% | +55.9% | -59.9% | |
| May 22, 2023 | IRWD Ironwood Pharmaceuticals Inc | SVP, Chief Business Officer | Sell | 6,305 | $10.12 | $63,806.60 | -2.8% | -10.4% | -37.5% | |
| Feb 28, 2023 | IRWD Ironwood Pharmaceuticals Inc | SVP, Chief Business Officer | Sell | 3,573 | $11.36 | $40,585.73 | -1.2% | -4.6% | +34.2% | |
| Nov 21, 2022 | IRWD Ironwood Pharmaceuticals Inc | SVP, Chief Business Officer | Sell | 3,335 | $11.56 | $38,552.60 | -2.1% | +1.7% | -18.2% |